- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease ; volume:9 ; number:1 ; day:28 ; month:2 ; year:2019 ; pages:1-10 ; date:12.2019
Scientific reports ; 9, Heft 1 (28.2.2019), 1-10, 12.2019
- Creator
-
Lee, Chi Fung
Caudal, Arianne
Abell, Lauren
Nagana Gowda, G. A.
Tian, Rong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-39419-4
- URN
-
urn:nbn:de:101:1-2019032022053341937107
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Chi Fung
- Caudal, Arianne
- Abell, Lauren
- Nagana Gowda, G. A.
- Tian, Rong
- SpringerLink (Online service)
Other Objects (12)
Targeting mitochondrial metabolism for precision medicine in cancer
Targeting NAD Metabolism for the Therapy of Age-Related Neurodegenerative Diseases
Emerging therapeutic roles for NAD+ metabolism in mitochondrial and age-related disorders
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Enzymology of extracellular NAD metabolism
Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism
Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells
Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia
Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment
The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism
Mitochondrial PARP1 regulates NAD+-dependent poly ADP-ribosylation of mitochondrial nucleoids
Targeting mitochondrial metabolism for precision medicine in cancer
Targeting NAD Metabolism for the Therapy of Age-Related Neurodegenerative Diseases
Emerging therapeutic roles for NAD+ metabolism in mitochondrial and age-related disorders
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Enzymology of extracellular NAD metabolism
Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism
Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells
Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia
Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment
The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism
Mitochondrial PARP1 regulates NAD+-dependent poly ADP-ribosylation of mitochondrial nucleoids
Targeting mitochondrial metabolism for precision medicine in cancer
Targeting NAD Metabolism for the Therapy of Age-Related Neurodegenerative Diseases
Emerging therapeutic roles for NAD+ metabolism in mitochondrial and age-related disorders
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Enzymology of extracellular NAD metabolism
Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism
Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells
Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia
Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment
The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism